47 related articles for article (PubMed ID: 29427761)
1. Status of Helicobacter pylori cag pathogenicity island (cagPAI) integrity and significance of its individual genes.
Markovska R; Boyanova L; Yordanov D; Stankova P; Gergova G; Mitov I
Infect Genet Evol; 2018 Apr; 59():167-171. PubMed ID: 29427761
[TBL] [Abstract][Full Text] [Related]
2. Presence of
Miernyk KM; Bruden D; Rudolph KM; Hurlburt DA; Sacco F; McMahon BJ; Bruce MG
J Med Microbiol; 2020 Feb; 69(2):218-227. PubMed ID: 32011229
[No Abstract] [Full Text] [Related]
3. Functional analysis of the cag pathogenicity island in Helicobacter pylori isolates from patients with gastritis, peptic ulcer, and gastric cancer.
Backert S; Schwarz T; Miehlke S; Kirsch C; Sommer C; Kwok T; Gerhard M; Goebel UB; Lehn N; Koenig W; Meyer TF
Infect Immun; 2004 Feb; 72(2):1043-56. PubMed ID: 14742552
[TBL] [Abstract][Full Text] [Related]
4. Identification of cagA tyrosine phosphorylation DNA motifs in Helicobacter pylori isolates from peptic ulcer patients by novel PCR-restriction fragment length polymorphism and real-time fluorescence PCR assays.
Owen RJ; Sharp SI; Chisholm SA; Rijpkema S
J Clin Microbiol; 2003 Jul; 41(7):3112-8. PubMed ID: 12843050
[TBL] [Abstract][Full Text] [Related]
5. Host immune response mediates changes in
Jang S; Hansen LM; Su H; Solnick JV; Cha JH
Gut Microbes; 2022; 14(1):2044721. PubMed ID: 35289715
[No Abstract] [Full Text] [Related]
6. CagA EPIYA polymorphisms in Colombian Helicobacter pylori strains and their influence on disease-associated cellular responses.
Fajardo CA; Quiroga AJ; Coronado A; Labrador K; Acosta N; Delgado P; Jaramillo C; Bravo MM
World J Gastrointest Oncol; 2013 Mar; 5(3):50-9. PubMed ID: 23671731
[TBL] [Abstract][Full Text] [Related]
7. NF-kappaB and ERK-signaling pathways contribute to the gene expression induced by cag PAI-positive-Helicobacter pylori infection.
Shibata W; Hirata Y; Yoshida H; Otsuka M; Hoshida Y; Ogura K; Maeda S; Ohmae T; Yanai A; Mitsuno Y; Seki N; Kawabe T; Omata M
World J Gastroenterol; 2005 Oct; 11(39):6134-43. PubMed ID: 16273640
[TBL] [Abstract][Full Text] [Related]
8. Genetic diversity of Helicobacter pylori type IV secretion system cagI and cagN genes and their association with clinical diseases.
Azizimoghaddam Y; Kermanpour S; Mirzaei N; Houri H; Nabavi-Rad A; Asadzadeh Aghdaei H; Yadegar A; Zali MR
Sci Rep; 2023 Jun; 13(1):10264. PubMed ID: 37355714
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the type IV secretion system from antibiotic-resistant
Oudouhou F; Morin C; Bouin M; Gaudreau C; Baron C
Can J Microbiol; 2024 Apr; 70(4):119-127. PubMed ID: 38176008
[No Abstract] [Full Text] [Related]
10. Quantitative evaluation of inflammatory and immune responses in the early stages of chronic Helicobacter pylori infection.
Straubinger RK; Greiter A; McDonough SP; Gerold A; Scanziani E; Soldati S; Dailidiene D; Dailide G; Berg DE; Simpson KW
Infect Immun; 2003 May; 71(5):2693-703. PubMed ID: 12704144
[TBL] [Abstract][Full Text] [Related]
11. Variations in cag pathogenicity island genes of Helicobacter pylori from Latin American groups may influence neoplastic progression to gastric cancer.
Rizzato C; Torres J; Obazee O; Camorlinga-Ponce M; Trujillo E; Stein A; Mendez-Tenorio A; Bravo MM; Canzian F; Kato I
Sci Rep; 2020 Apr; 10(1):6570. PubMed ID: 32300197
[TBL] [Abstract][Full Text] [Related]
12. Mixed (multiple-genotype) Helicobacter pylori infections in Bulgarian patients.
Boyanova L; Boyanova L; Hadzhiyski P; Kandilarov N; Yordanov D; Gergova R; Markovska R
Diagn Microbiol Infect Dis; 2023 Dec; 107(4):116073. PubMed ID: 37717293
[TBL] [Abstract][Full Text] [Related]
13. Impact of cagPAI and T4SS on the inflammatory response of human neutrophils to Helicobacter pylori infection.
Sánchez-Zauco NA; Torres J; Pérez-Figueroa GE; Álvarez-Arellano L; Camorlinga-Ponce M; Gómez A; Giono-Cerezo S; Maldonado-Bernal C
PLoS One; 2014; 8(6):e64623. PubMed ID: 23755130
[TBL] [Abstract][Full Text] [Related]
14. Genomic population structure of
Yang F; Zhang J; Wang S; Sun Z; Zhou J; Li F; Liu Y; Ding L; Liu Y; Chi W; Liu T; He Y; Xiang P; Bao Z; Olszewski MA; Zhao H; Zhang Y
Virulence; 2021 Dec; 12(1):1258-1270. PubMed ID: 33904371
[TBL] [Abstract][Full Text] [Related]
15. Influence of Helicobacter pylori virulence factors CagA and VacA on pathogenesis of gastrointestinal disorders.
Nejati S; Karkhah A; Darvish H; Validi M; Ebrahimpour S; Nouri HR
Microb Pathog; 2018 Apr; 117():43-48. PubMed ID: 29432909
[TBL] [Abstract][Full Text] [Related]
16. Biological properties and pathogenicity factors of Helicobacter pylori.
Isaeva GS; Fagoonee S
Minerva Gastroenterol Dietol; 2018 Sep; 64(3):255-266. PubMed ID: 29442488
[TBL] [Abstract][Full Text] [Related]
17. Structural and Molecular Biology of Type IV Secretion Systems.
Bergé C; Waksman G; Terradot L
Curr Top Microbiol Immunol; 2017; 413():31-60. PubMed ID: 29536354
[TBL] [Abstract][Full Text] [Related]
18.
Ansari S; Yamaoka Y
Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31752394
[No Abstract] [Full Text] [Related]
19. Helicobacter pylori type 4 secretion systems as gastroduodenal disease markers.
Phuc BH; Tuan VP; Dung HDQ; Binh TT; Tung PH; Tri TD; Thuan NPM; Van Khien V; Trang TTH; Akada J; Matsumoto T; Yamaoka Y
Sci Rep; 2021 Feb; 11(1):4584. PubMed ID: 33633144
[TBL] [Abstract][Full Text] [Related]
20. Alterations of Fucosyltransferase Genes and Fucosylated Glycans in Gastric Epithelial Cells Infected with
Fan R; Han X; Gong Y; He L; Xue Z; Yang Y; Sun L; Fan D; You Y; Meng F; Yan X; Zhang M; Zhang J
Pathogens; 2021 Feb; 10(2):. PubMed ID: 33557187
[No Abstract] [Full Text] [Related]
[Next] [New Search]